FDA Approves Evenity for Osteoporosis

Evenity (romosozumab-aqqg) has been approved to treat postmenopausal women at high risk of bone fractures.

Source: ConsultantLive - April 10, 2019 Category: Internal Medicine Authors: Valerie DeBenedette Tags: New Products Source Type: news